Unfortunately, MVP is a one trick pony. The respiratory products do not produce enough revenue and are unlikely to grow significantly. Lot's of growth to come from Penthrox but that leaves MVP open to risk from competitors.
Movement, page-51
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MVP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
44.3¢ |
Change
-0.023(4.84%) |
Mkt cap ! $50.41M | |||
| Open | High | Low | Value | Volume |
| 45.5¢ | 45.5¢ | 44.3¢ | $28.66K | 63.67K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 49660 | 44.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.0¢ | 2088 | 2 |
View Market Depth
| Last trade - 15.07pm 07/11/2024 (20 minute delay) ? |
| MVP (ASX) Chart |